Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Jan;34(1):87–89. doi: 10.1136/jcp.34.1.87

Bacteraemia due to a rifampicin-resistant strain of Bacteroides fragilis.

D W Bullock, A J Webb, B I Duerden, V O Rotimi
PMCID: PMC1146419  PMID: 7462441

Abstract

A strain of Bacteroides fragilis with high-level chromosomal resistance to rifampicin was isolated by blood culture from a patient with bacteraemia after gastrointestinal surgery. He had been receiving antituberculous therapy with rifampicin for nine months. This resistance led to some difficulty in the recognition and identification of the isolate by methods that depended upon antibiotic sensitivity patterns.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas E., Turck M. Laboratory and clinical evaluation of rifampicin. Am J Med Sci. 1968 Oct;256(4):47–54. [PubMed] [Google Scholar]
  2. Brefort G., Magot M., Ionesco H., Sebald M. Characterization and transferability of Clostridium perfringens plasmids. Plasmid. 1977 Nov;1(1):52–66. doi: 10.1016/0147-619x(77)90008-7. [DOI] [PubMed] [Google Scholar]
  3. Duerden B. I., Collee J. G., Brown R., Deacon A. G., Holbrook W. P. A scheme for the identification of clinical isolates of Gram-negative anaerobic bacilli by conventional bacteriological tests. J Med Microbiol. 1980 May;13(2):231–245. doi: 10.1099/00222615-13-2-231. [DOI] [PubMed] [Google Scholar]
  4. Duerden B. I., Holbrook W. P., Collee J. G., Watt B. The characterization of clinically important gram negative anaerobic bacilli by conventional bacteriological tests. J Appl Bacteriol. 1976 Apr;40(2):163–188. doi: 10.1111/j.1365-2672.1976.tb04164.x. [DOI] [PubMed] [Google Scholar]
  5. Felner J. M., Dowell V. R., Jr "Bacteroides" bacteremia. Am J Med. 1971 Jun;50(6):787–796. doi: 10.1016/0002-9343(71)90187-2. [DOI] [PubMed] [Google Scholar]
  6. Greenwood D., Andrew J. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection. J Antimicrob Chemother. 1978 Nov;4(6):533–538. doi: 10.1093/jac/4.6.533. [DOI] [PubMed] [Google Scholar]
  7. Kerry D. W., Hamilton-Miller J. M., Brumfitt W. Trimethoprim and rifampicin: in vitro activities separately and in combination. J Antimicrob Chemother. 1975 Dec;1(4):417–427. doi: 10.1093/jac/1.4.417. [DOI] [PubMed] [Google Scholar]
  8. McCabe W. R., Lorian V. Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci. 1968 Oct;256(4):255–265. doi: 10.1097/00000441-196810000-00007. [DOI] [PubMed] [Google Scholar]
  9. Morris R. I., Metzger A. L., Bluestone R., Terasaki P. I. HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease. N Engl J Med. 1974 May 16;290(20):1117–1119. doi: 10.1056/NEJM197405162902004. [DOI] [PubMed] [Google Scholar]
  10. Stiffler P. W., Keller R., Traub N. Isolation and characterization of several cryptic plasmids from clinical isolates of Bacteroides fragilis. J Infect Dis. 1974 Nov;130(5):544–548. doi: 10.1093/infdis/130.5.544. [DOI] [PubMed] [Google Scholar]
  11. Sutter V. L., Finegold S. M. Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. Appl Microbiol. 1971 Jan;21(1):13–20. doi: 10.1128/am.21.1.13-20.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Werner H. The susceptibility of bacteroides, fusobacterium leptotrichia, and sphaerophorus strains to rifampicin. Arzneimittelforschung. 1972 Jun;22(6):1043–1045. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES